Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael N Pollak

Showing results (31-40 of 175) with videos related to

Pageof 18
Sort By:
American Journal of Epidemiology|July 1, 2015
A prospective study of insulin-like growth factor 1, its binding protein 3, and risk of endometriosisFan Mu, Susan E Hankinson, Eva Schernhammer, et al.
Epidemiology (Cambridge, Mass.)|December 29, 2017
Incretin-based Drugs and the Incidence of Colorectal Cancer in Patients with Type 2 DiabetesDevin Abrahami, Hui Yin, Oriana H Y Yu, et al.
Npj Aging|May 8, 2026
Circulating levels of insulin-like growth factor binding protein 7 are associated with risks of chronic diseases and deathZhi Li, Chengzhe Tao, Ziyi Zhou, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 13, 2006
No association between serum insulin-like growth factor (IGF)-I, IGF-binding protein-3, and lung cancer riskJiyoung Ahn, Stephanie J Weinstein, Kirk Snyder, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 16, 2007
Circulating insulin and c-peptide levels and risk of breast cancer among predominately premenopausal womenA Heather Eliassen, Shelley S Tworoger, Christos S Mantzoros, et al.
International Journal of Cancer|August 20, 2003
Polymorphic variation at the -202 locus in IGFBP3: Influence on serum levels of insulin-like growth factors, interaction with plasma retinol and vitamin D and breast cancer riskEva S Schernhammer, Susan E Hankinson, David J Hunter, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 21, 2005
Racial differences in premenopausal endogenous hormonesSimone P Pinheiro, Michelle D Holmes, Michael N Pollak, et al.
Endocrine-Related Cancer|May 27, 2006
Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study IIEva S Schernhammer, Jeff M Holly, David J Hunter, et al.
Science (New York, N.Y.)|January 26, 2023
Structural basis of mammalian respiratory complex I inhibition by medicinal biguanidesHannah R Bridges, James N Blaza, Zhan Yin, et al.
The Prostate|February 19, 2010
Androgens, growth factors, and risk of prostate cancer: the Multiethnic CohortJasmeet K Gill, Lynne R Wilkens, Michael N Pollak, et al.
Pageof 18

Showing results (31-40 of 175) with videos related to

Sort By:
Pageof 18
American Journal of Epidemiology|July 1, 2015
A prospective study of insulin-like growth factor 1, its binding protein 3, and risk of endometriosisFan Mu, Susan E Hankinson, Eva Schernhammer, et al.
Epidemiology (Cambridge, Mass.)|December 29, 2017
Incretin-based Drugs and the Incidence of Colorectal Cancer in Patients with Type 2 DiabetesDevin Abrahami, Hui Yin, Oriana H Y Yu, et al.
Npj Aging|May 8, 2026
Circulating levels of insulin-like growth factor binding protein 7 are associated with risks of chronic diseases and deathZhi Li, Chengzhe Tao, Ziyi Zhou, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 13, 2006
No association between serum insulin-like growth factor (IGF)-I, IGF-binding protein-3, and lung cancer riskJiyoung Ahn, Stephanie J Weinstein, Kirk Snyder, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 16, 2007
Circulating insulin and c-peptide levels and risk of breast cancer among predominately premenopausal womenA Heather Eliassen, Shelley S Tworoger, Christos S Mantzoros, et al.
International Journal of Cancer|August 20, 2003
Polymorphic variation at the -202 locus in IGFBP3: Influence on serum levels of insulin-like growth factors, interaction with plasma retinol and vitamin D and breast cancer riskEva S Schernhammer, Susan E Hankinson, David J Hunter, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 21, 2005
Racial differences in premenopausal endogenous hormonesSimone P Pinheiro, Michelle D Holmes, Michael N Pollak, et al.
Endocrine-Related Cancer|May 27, 2006
Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study IIEva S Schernhammer, Jeff M Holly, David J Hunter, et al.
Science (New York, N.Y.)|January 26, 2023
Structural basis of mammalian respiratory complex I inhibition by medicinal biguanidesHannah R Bridges, James N Blaza, Zhan Yin, et al.
The Prostate|February 19, 2010
Androgens, growth factors, and risk of prostate cancer: the Multiethnic CohortJasmeet K Gill, Lynne R Wilkens, Michael N Pollak, et al.
Pageof 18